AGP Executive Report
Last update: 2 hours agoChildhood Obesity: The WHO advises against weight-loss drugs for young children with obesity, a caution with implications for families and clinicians in Germany as well as worldwide. Drug Access: A Dutch court has barred sales of subcutaneous Keytruda in eight European countries, adding uncertainty around access to a widely used cancer treatment. Gene Therapy: Germany has treated its first patient with CRISPR therapy since the treatment was approved, marking a milestone for advanced care. Brain Research: German scientists Peter Hegemann and Georg Nagel shared the 2026 Nobel Prize in Medicine with US researcher Karl Deisseroth for work that enabled nerve cells to be controlled with light. Elder Care: A report warns that the German government’s reform plans could deepen the country’s elderly-care crisis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.